Publication:
Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure

dc.contributor.authorTasal, Abdurrahman
dc.contributor.authorDEMİR, MESUT
dc.contributor.authorKANADAŞI, MEHMET
dc.contributor.authorBACAKSIZ, AHMET
dc.contributor.authorVatankulu, Mehmet Akif
dc.contributor.authorSahin, Durmus Yildiray
dc.contributor.authorEker, Rabia Akilli
dc.contributor.authorBOZKURT, ABDİ
dc.contributor.authorAcarturk, Esmeray
dc.contributor.institutionauthorBACAKSIZ, AHMET
dc.date.accessioned2020-10-22T18:35:35Z
dc.date.available2020-10-22T18:35:35Z
dc.date.issued2014-02-01T00:00:00Z
dc.description.abstractBackground: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.
dc.identifier.citationTasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , Eker R. A. , BOZKURT A., Acarturk E., -Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure-, MEDICAL SCIENCE MONITOR, cilt.20, 2014
dc.identifier.doi10.12659/msm.889767
dc.identifier.pubmed24549281
dc.identifier.scopus84896695793
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24231
dc.identifier.wosWOS:000331933500001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleComparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure
dc.typeArticle
dspace.entity.typePublication
local.avesis.id9661f6db-804d-4783-920d-ca149977261e
local.publication.isinternational1
relation.isAuthorOfPublicationaf75b431-3b28-42b6-93a9-357a5d965904
relation.isAuthorOfPublication.latestForDiscoveryaf75b431-3b28-42b6-93a9-357a5d965904
Files